Increase of angiotensin II type 1 receptor auto-antibodies in Huntington's disease. - Wikidata - wikimedia - TriplyDB

Increase of angiotensin II type 1 receptor auto-antibodies in Huntington's disease.

Increase of angiotensin II type 1 receptor auto-antibodies in Huntington's disease.

http://www.wikidata.org/entity/Q34581918

about

The choreography of neuroinflammation in Huntington's disease Angiotensins and Huntington's Disease: A Study on Immortalized Progenitor Striatal Cell Lines.The Prognostic Role of Angiotensin II Type 1 Receptor Autoantibody in Non-Gravid Hypertension and Pre-eclampsia: A Meta-analysis and Our Studies

P2860

Q26828403-B91FB872-18C5-4439-B923-520D8570B3F1 Q33720370-E059CB21-94CF-4A17-9A96-7FD4C5E47E8D Q37206448-23586986-8549-4C56-B537-D6A1BD833F44

P2860

Increase of angiotensin II type 1 receptor auto-antibodies in Huntington's disease.

http://www.wikidata.org/entity/Q34581918

description

2014 nî lūn-bûn

@nan

2014 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած

@hyw

2014 թվականի նոյեմբերին հրատարակված գիտական հոդված

@hy

2014年の論文

@ja

2014年学术文章

@wuu

2014年学术文章

@zh-cn

2014年学术文章

@zh-hans

2014年学术文章

@zh-my

2014年学术文章

@zh-sg

2014年學術文章

@yue

name

Increase of angiotensin II type 1 receptor auto-antibodies in Huntington's disease.

@ast

Increase of angiotensin II type 1 receptor auto-antibodies in Huntington's disease.

@en

Increase of angiotensin II type 1 receptor auto-antibodies in Huntington's disease.

@nl

type

label

Increase of angiotensin II type 1 receptor auto-antibodies in Huntington's disease.

@ast

Increase of angiotensin II type 1 receptor auto-antibodies in Huntington's disease.

@en

Increase of angiotensin II type 1 receptor auto-antibodies in Huntington's disease.

@nl

prefLabel

Increase of angiotensin II type 1 receptor auto-antibodies in Huntington's disease.

@ast

Increase of angiotensin II type 1 receptor auto-antibodies in Huntington's disease.

@en

Increase of angiotensin II type 1 receptor auto-antibodies in Huntington's disease.

@nl

P1433

Q34581918-7AB231BB-3F19-457A-AFDE-B037DDBF5A01

P1476

Q34581918-791AF490-549E-4BA4-82B0-D2B8C1C1C9B4

P2093

Q34581918-0F9AA94C-F397-4950-AE69-6F8377324F62

Q34581918-28479B2A-ECFD-41C9-B8CB-CBF46235598E

Q34581918-2C125A05-C88E-4FA5-9C06-29ED4ABBA2E1

Q34581918-416DE797-0E03-4B90-ADA1-6A06518AFE96

Q34581918-787D9E02-87D9-4494-8BC1-EDDB17BC2A03

Q34581918-8010E12B-E3A4-40D0-9AD7-42B787FA079C

Q34581918-8A34D24D-7B22-4BED-BCFD-24CF06190392

Q34581918-ABC465B2-B1B5-4A6C-93E7-7923CCF9EB2B

Q34581918-C17BCA55-814F-4D52-985A-1BE4774C10EB

Q34581918-D9581BB5-8336-4E25-AE25-46E1973DDE08

P2860

Q34581918-05B5AFF0-DDEC-47F9-AFF4-DF7AE5BB173F

Q34581918-05E8E785-16B4-4771-8B09-585451F47A2C

Q34581918-150493E9-59C3-46AA-9A45-544F1EA9942C

Q34581918-192275A2-C145-43B4-8A27-C615F3BCE364

Q34581918-1AFB0FBE-B00E-4300-BE72-E9B4C0DFA6D2

Q34581918-1D6B9B28-881E-46D5-A950-86F6D63FD0E6

Q34581918-25D36543-1CDE-49FC-A416-054C5808E3B7

Q34581918-34213142-948C-46D3-B65A-8B3B70973D0A

Q34581918-38EE726A-8222-406E-A5A5-5F41DDF746E0

Q34581918-4453ECE7-54F7-43D9-AAF0-E7C19EF7E613

P2888

Q34581918-F70A5B03-EC65-4451-92E3-81920C2AEA97

P304

Q34581918-F9F00095-7783-44FE-87DA-53C8ECB6465E

P31

Q34581918-85F2DA7B-AFFA-4110-8AF9-7860880EA99D

P356

Q34581918-31953DAD-FB15-489A-8E0A-FE3A8A2FDF4F

P478

Q34581918-03FC6061-F2E3-4459-84F5-5872689B5C93

P50

Q34581918-07A6ADC7-2542-440E-A480-79E46D88EA21

Q34581918-15C40867-9581-4995-840B-B0A0EABAFE52

Q34581918-5403AE9A-5C06-40E7-8394-6B383EB89381

Q34581918-E2079FDC-289E-4FDF-B229-D4EA7F43FB07

P577

Q34581918-6EE800EE-AA2B-46F1-9FF4-D4936A8B399B

P5875

Q34581918-2502E5A6-1BD5-4F33-8180-614E6843EA5E

P6179

Q34581918-6ABC2CF4-AB88-49D4-8FAB-EC57D75B93DC

P698

Q34581918-6E4F9899-6CA3-43FD-990C-929A503E0833

P921

Q34581918-147F637C-6D20-4C60-AC5D-CA406B2AFA35

P932

Q34581918-B5DA597A-E923-4685-994A-25DF1163DD71

P356

P1433

Molecular Neurodegeneration

P1476

Increase of angiotensin II type 1 receptor auto-antibodies in Huntington's disease.

@en

P2093

Alexandra Schröder

http://www.w3.org/2001/XMLSchema#string

Anne Waschbisch

http://www.w3.org/2001/XMLSchema#string

De-Hyung Lee

http://www.w3.org/2001/XMLSchema#string

Dominik N Müller

http://www.w3.org/2001/XMLSchema#string

Duska Dragun

http://www.w3.org/2001/XMLSchema#string

Gisa Ellrichmann

http://www.w3.org/2001/XMLSchema#string

Harald Heidecke

http://www.w3.org/2001/XMLSchema#string

Johannes Stegbauer

http://www.w3.org/2001/XMLSchema#string

Peter Klotz

http://www.w3.org/2001/XMLSchema#string

Rainer Hoffmann

http://www.w3.org/2001/XMLSchema#string

P2860

Diagnostic criteria for multiple sclerosis: 2010 revisions to the McDonald criteria

A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington's disease chromosomes.

Potassium channel KIR4.1 as an immune target in multiple sclerosis

Neuroinflammation in Parkinson's disease: a target for neuroprotection?

Progressive alterations in the hypothalamic-pituitary-adrenal axis in the R6/2 transgenic mouse model of Huntington's disease.

Efficacy of fumaric acid esters in the R6/2 and YAC128 models of Huntington's disease.

Mutant Huntingtin promotes autonomous microglia activation via myeloid lineage-determining factors

Association between caffeine intake and age at onset in Huntington's disease.

A novel pathogenic pathway of immune activation detectable before clinical onset in Huntington's disease

The inflammatory response in Alzheimer's disease.

P2888

P304

49

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1186/1750-1326-9-49

http://www.w3.org/2001/XMLSchema#string

P478

9

http://www.w3.org/2001/XMLSchema#string

P50

Friedemann Paul

P577

2014-11-15T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

268392350

http://www.w3.org/2001/XMLSchema#string

P6179

1002399517

http://www.w3.org/2001/XMLSchema#string

P698

25398321

http://www.w3.org/2001/XMLSchema#string

P921

Huntington disease

P932

4246494

http://www.w3.org/2001/XMLSchema#string